Cargando…

Conversion to Everolimus was Beneficial and Safe for Fast and Slow Tacrolimus Metabolizers after Renal Transplantation

Fast tacrolimus (TAC) metabolism (concentration/dose (C/D) ratio <1.05 ng/mL/mg) is a risk factor for inferior outcomes after renal transplantation (RTx) as it fosters, e.g., TAC-related nephrotoxicity. TAC minimization or conversion to calcineurin-inhibitor free immunosuppression are strategies...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thölking, Gerold, Gillhaus, Nils Hendrik, Schütte-Nütgen, Katharina, Pavenstädt, Hermann, Koch, Raphael, Suwelack, Barbara, Reuter, Stefan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7074544/ https://www.ncbi.nlm.nih.gov/pubmed/31979381 http://dx.doi.org/10.3390/jcm9020328

Ejemplares similares

The Tacrolimus Metabolism Rate and Dyslipidemia after Kidney Transplantation
por: Thölking, Gerold, et al.
Publicado: (2021)

Increased renal function decline in fast metabolizers using extended-release tacrolimus after kidney transplantation
por: Thölking, Gerold, et al.
Publicado: (2021)

Fast Tac Metabolizers at Risk—It is Time for a C/D Ratio Calculation
por: Schütte-Nütgen, Katharina, et al.
Publicado: (2019)

Correction: Fast Tac Metabolizers at Risk—It is Time for a C/D Ratio Calculation. J. Clin. Med. 2019, 8, 587
por: Schütte-Nütgen, Katharina, et al.
Publicado: (2019)

Clinical features of BK-polyomavirus and cytomegalovirus co-infection after kidney transplantation
por: Jehn, Ulrich, et al.
Publicado: (2020)

Expanding the donor pool in kidney transplantation: Should organs with acute kidney injury be accepted?—A retrospective study
por: Schütte-Nütgen, Katharina, et al.
Publicado: (2019)

A Low Tacrolimus Concentration/Dose Ratio Increases the Risk for the Development of Acute Calcineurin Inhibitor-Induced Nephrotoxicity
por: Thölking, Gerold, et al.
Publicado: (2019)

Cytomegalovirus Viremia after Living and Deceased Donation in Kidney Transplantation
por: Jehn, Ulrich, et al.
Publicado: (2020)

Antihypertensive Treatment in Kidney Transplant Recipients—A Current Single Center Experience
por: Jehn, Ulrich, et al.
Publicado: (2020)

Improved Kidney Allograft Function after Early Conversion of Fast IR-Tac Metabolizers to LCP-Tac
por: Thölking, Gerold, et al.
Publicado: (2022)

Is there a "weekend effect" in kidney transplantation?
por: Schütte-Nütgen, Katharina, et al.
Publicado: (2017)

The Tacrolimus Metabolism Rate Influences Renal Function after Kidney Transplantation
por: Thölking, Gerold, et al.
Publicado: (2014)

Influence of tacrolimus metabolism rate on BKV infection after kidney transplantation
por: Thölking, Gerold, et al.
Publicado: (2016)

The Influence of Parathyroidectomy on Osteoporotic Fractures in Kidney Transplant Recipients: Results from a Retrospective Single-Center Trial
por: Jehn, Ulrich, et al.
Publicado: (2022)

Fast Tacrolimus Metabolism Does Not Promote Post-Transplant Diabetes Mellitus after Kidney Transplantation
por: Jehn, Ulrich, et al.
Publicado: (2022)

Validation of the Kidney Donor Profile Index (KDPI) to assess a deceased donor’s kidneys’ outcome in a European cohort
por: Dahmen, Maximilian, et al.
Publicado: (2019)

The Effect of Proton Pump Inhibitor Use on Renal Function in Kidney Transplanted Patients
por: Flothow, Dominik J. G., et al.
Publicado: (2020)

Soluble urokinase-type plasminogen activator receptor (suPAR) is a risk indicator for eGFR loss in kidney transplant recipients
por: Jehn, Ulrich, et al.
Publicado: (2021)

Antigen-Specific versus Non-Antigen-Specific Immunoadsorption in ABO-Incompatible Renal Transplantation
por: Thölking, Gerold, et al.
Publicado: (2015)

Prognostic Value of Growth Differentiation Factor 15 in Kidney Donors and Recipients
por: Jehn, Ulrich, et al.
Publicado: (2020)

Male kidney allograft recipients at risk for urinary tract infection?
por: Thölking, Gerold, et al.
Publicado: (2017)

A Comparison of Different Algorithms for the Assessment of Cardiovascular Risk in Patients at Waiting List for Kidney Transplantation
por: Reuter, Stefan, et al.
Publicado: (2016)

Commentary: The Clinical Impact of the C(0)/D Ratio and the CYP3A5 Genotype on Outcome in Tacrolimus Treated Kidney Transplant Recipients
por: Thölking, Gerold, et al.
Publicado: (2021)

Influence of tacrolimus metabolism rate on renal function after solid organ transplantation
por: Thölking, Gerold, et al.
Publicado: (2017)

Assessment of Hemostasis after Plasma Exchange Using Rotational Thrombelastometry (ROTEM)
por: Thölking, Gerold, et al.
Publicado: (2015)

Conversion from Standard-Release Tacrolimus to MeltDose(®) Tacrolimus (LCPT) Improves Renal Function after Liver Transplantation
por: von Einsiedel, Johannes, et al.
Publicado: (2020)

Tacrolimus-Induced Salt Losing Nephropathy Resolved After Conversion to Everolimus
por: Sayin, Burak
Publicado: (2015)

Tacrolimus-induced gingival hyperplasia and recovery from tacrolimus to everolimus switching
por: Oral, Alihan, et al.
Publicado: (2019)

Phenotypic and Genotypic Characterization of Escherichia coli Causing Urinary Tract Infections in Kidney-Transplanted Patients
por: Abo Basha, Jonas, et al.
Publicado: (2019)

Comparison of kidney allograft survival in the Eurotransplant senior program after changing the allocation criteria in 2010—A single center experience
por: Mehdorn, Anne-Sophie, et al.
Publicado: (2020)

Tumor Recurrence and Graft Survival in Renal Transplant Recipients with a History of Pretransplant Malignancy: A Matched Pair Analysis
por: Becker, Felix, et al.
Publicado: (2021)

Everolimus/prednisolone/tacrolimus: COVID-19 infection: case report
Publicado: (2021)

First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient
por: Jehn, Ulrich, et al.
Publicado: (2022)

Combination of everolimus and tacrolimus: a potentially effective regimen for recalcitrant psoriasis
por: Wei, Kai-Che, et al.
Publicado: (2015)

Tremor Induced by Cyclosporine, Tacrolimus, Sirolimus, or Everolimus: A Review of the Literature
por: Wagle Shukla, Aparna, et al.
Publicado: (2023)

Case Report: Management of a Multidrug-Resistant CMV-Strain in a Renal Transplant Recipient by High-Dose CMV-Specific Immunoglobulins, Modulation in Immunosuppression, and Induction of CMV-Specific Cellular Immunity
por: Wiening, Vanessa, et al.
Publicado: (2021)

Everolimus/prednisone/tacrolimus: Primary lung adenocarcinoma and lymphangitic carcinomatosis: case report
Publicado: (2018)

Utilization of Mycophenolic Acid, Azathioprine, Tacrolimus, Cyclosporin, Sirolimus, and Everolimus: Multinational Study
por: Sahman, Majda, et al.
Publicado: (2021)

Impact of High-Cut-Off Dialysis on Renal Recovery in Dialysis-Dependent Multiple Myeloma Patients: Results from a Case-Control Study
por: Gerth, Hans U., et al.
Publicado: (2016)

Prognostic implication of myocardial perfusion and contractile reserve in end-stage renal disease: A direct comparison of myocardial perfusion scintigraphy and dobutamine stress echocardiography
por: Bautz, Joachim, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ep2vfeqptq2dgavmg1r6hk2bkb